BIONTECH SE DRN revenue breakdown overview

BIONTECH SE DRN revenue for the last year amounted to 17.66 B BRL, the most of which — 18.45 B BRL — came from its highest performing source at the moment, Immunotherapy Technologies, the year earlier bringing 20.07 B BRL. The greatest contribution to the revenue figure was made by United States — last year it brought BIONTECH SE DRN 12.39 B BRL, and the year before that — 15.82 B BRL.